Clinical impact of recent surge in acute parvovirus B19 infections in Leicester UK, March

Clinical impact of recent surge in acute parvovirus B19 infections in Leicester UK, March–July 2024

Published:2024-09 Issue:9 Volume:96 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Tabassum Nabila¹,Bhuller Kaljit¹,Webster Amy²,Siddiqui Farah³,Dunkerton Suzanna³,Khare Manjiri³,Eamonn Breslin³,Mousa Hatem A.³,Scudamore Ian³,Roland Damian⁴,Rowlands Rachel⁴,Bandi Srini⁵,Rai Vinayak R.⁵,Bagul Atul⁶,Jesus‐Silva Jorge⁶^ORCID,Bird Paul W.⁷⁸^ORCID,Young Sarah R.⁷,James Lucy⁷,Toovey Oliver T. R.⁷,Tang Julian W.⁷⁸^ORCID

Affiliation:

1. Department of Paediatric Haematology University Hospitals of Leicester NHS Trust Leicester UK

2. Department of Adult Haematology University Hospitals of Leicester NHS Trust Leicester UK

3. Department of Fetal Medicine Unit University Hospitals of Leicester NHS Trust Leicester UK

4. Department of Paediatric Emergency University Hospitals of Leicester NHS Trust Leicester UK

5. Department of Paediatrics University Hospitals of Leicester NHS Trust Leicester UK

6. Department of Nephrology and Transplant University Hospitals of Leicester NHS Trust Leicester UK

7. Department of Clinical Microbiology University Hospitals of Leicester NHS Trust Leicester UK

8. Department of Respiratory Sciences University of Leicester Leicester UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29903

Reference10 articles.

1. An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024;d'Humières C;Euro Surveill,2024

2. Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024

3. European Centre for Disease Prevention and Control.Risks posed by reported increased circulation of human parvovirus B19 in the EU/EEA. 5 June2024.https://www.ecdc.europa.eu/en/publications-data/risks-posed-reported-increased-circulation-human-parvovirus-b19-eueea(Accessed 15 July 2024)

4. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection

5. Intravenous Immunoglobulin Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection: A Retrospective Study of 10 Patients and Review of the Literature